Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
125 studies found for:    Open Studies | "Skin Diseases, Infectious"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Skin Diseases, Infectious"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Human Immunity Against Staphylococcus Aureus Skin Infection
Condition: Staphylococcus Aureus Skin Infection
Intervention: Other: Killed Bacteria
2 Recruiting Skin and Soft Tissue Infection (SSTI) Study
Conditions: Skin Diseases, Infectious;   Soft Tissue Infections
Interventions: Drug: Provodine;   Procedure: Incision and Drainage
3 Recruiting Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Conditions: Skin Diseases, Infectious;   Skin Diseases, Bacterial
Interventions: Drug: Tedizolid Phophate 200 mg, IV and/or oral for 6 days;   Drug: Antibiotic comparator
4 Recruiting Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
Conditions: Skin Diseases, Bacterial;   Abscess
Interventions: Biological: Linezolid;   Biological: Clindamycin
5 Not yet recruiting Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Bacterial Infections;   Staphylococcal Skin Infections
Interventions: Drug: Dalbavancin single dose;   Drug: Dalbavancin two dose;   Drug: Comparator
6 Recruiting Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
Condition: Cellulitis
Interventions: Other: Home;   Other: Ward;   Drug: ceftriaxone;   Drug: flucloxacillin
7 Recruiting Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Recurrence;   Staphylococcal Skin Infections;   Antibiotic Resistance
Interventions: Drug: 2% mupirocin ointment;   Other: Chlorhexidine wash;   Behavioral: Hygiene protocol
8 Not yet recruiting Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis
Condition: Tinea
Interventions: Drug: Ketoconazole + betamethasone dipropionate;   Drug: Clotrimazole + Dexamethasone acetate
9 Not yet recruiting Safety of Either a Single or Two IV Doses of Orbactiv in Subjects With ABSSSI
Condition: Skin Diseases, Bacterial
Interventions: Drug: oritavancin;   Drug: placebo (D5W)
10 Recruiting Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis
Condition: Cellulitis
Interventions: Drug: Prednisone;   Drug: Placebo
11 Recruiting Use of Corticosteroids in Children With Cellulitis
Condition: Cellulitis
Interventions: Drug: Dexamethasone;   Drug: Normal Saline
12 Recruiting Safety and Efficacy of Product 33525 in Pediatric Subjects With Tinea Corporis
Condition: Tinea Corporis
Interventions: Drug: Luliconazole Cream 1%;   Drug: Vehicle Cream
13 Not yet recruiting A Randomized Study Evaluating the Safety and Efficacy of Luliconazole Cream in Pediatric Subjects With Tinea Corporis
Condition: Tinea
Interventions: Drug: Luliconazole Cream 1%;   Drug: Vehicle Cream
14 Recruiting Duration of ANtibiotic Therapy for CEllulitis
Conditions: Cellulitis;   Erysipelas
Interventions: Drug: Flucloxacillin;   Drug: Placebo (for flucloxacillin)
15 Not yet recruiting Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco
Conditions: Cutaneous Leishmaniasis;   Skin Diseases, Parasitic;   Neglected Diseases
Intervention:
16 Recruiting CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
Condition: Candidiasis, Chronic Mucocutaneous
Intervention: Drug: Amphotericin B
17 Recruiting Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
Condition: Aspergillosis
Interventions: Drug: Posaconazole;   Drug: Voriconazole
18 Recruiting A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Condition: Fungal Infections
Interventions: Drug: Posaconazole;   Drug: Voriconazole
19 Recruiting Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers
Condition: Herpes Simplex Virus Infection
Intervention: Drug: UB-621
20 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.